Kenny John P.
- SEC CIK
- 0001719325
No open-market purchases or sales filed in the past year.
Current role at each company
- OSUR Orasure Technologies IncDirectoras of Sep 9, 2026
- NEO Neogenomics IncDirectoras of Jun 3, 2026
- QSI Quantum-Si IncDirectoras of May 20, 2026
- BMRA Biomerica IncDirectoras of Dec 14, 2023
- Meridian Bioscience IncChief Executive Officeras of Jan 31, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Kenny John P. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
OSUR Orasure Technologies Inc
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 27, 2025 (view filing) | Feb 27 | Same day | Kenny John P.Director | PPurchase | +47.7K | $3.17 | +$151.1K | +204.9%70.9K after |
Meridian Bioscience Inc
Chief Executive Officer2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 24, 2022 (view filing) | Jun 22-23 | 2 days | Kenny John P.Chief Executive Officer | SSale | −64.6K | $29.80 | −$1.93M | −19.6%265.1K after | 2 lots |
| Jun 28, 2022 (view filing) | Jun 24-27 | 4 days | Kenny John P.Chief Executive Officer | SSale | −75.0K | $30.32 | −$2.27M | −22.0%265.1K after | 2 lots |